Brief: VBL Therapeutics Reports Third Quarter 2021 Financial Results
15/11/2021 12:50
Nov 15 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* Q3 REVENUE $200,000
* QTRLY LOSS OF $0.09 PER BASIC SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
* Q3 REVENUE VIEW $150000.00 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8xHsd3
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives